Journal of the American Academy of Dermatology, 2008-05, Vol.58 (5), p.826-850
2008
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Guidelines of care for the management of psoriasis and psoriatic arthritis Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
- Ist Teil von
- Journal of the American Academy of Dermatology, 2008-05, Vol.58 (5), p.826-850
- Ort / Verlag
- New York, NY: Elsevier
- Erscheinungsjahr
- 2008
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this first of 5 sections of the guidelines of care for psoriasis, we discuss the classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues. Finally, we will discuss the safety and efficacy of the biologic treatments used to treat patients with psoriasis.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0190-9622eISSN: 1097-6787DOI: 10.1016/j.jaad.2008.02.039Titel-ID: cdi_pubmed_primary_18423260
- Format
- –
- Schlagworte
- Acitretin - adverse effects, Antibodies, Monoclonal - therapeutic use, Arthritis, Psoriatic - drug therapy, Biological and medical sciences, Biological Products - therapeutic use, Cardiovascular Diseases - etiology, Cyclosporine - therapeutic use, Depression - etiology, Dermatology, Diseases of the osteoarticular system, Etanercept, Humans, Immunoglobulin G - adverse effects, Inflammatory joint diseases, Interleukin-12 - antagonists & inhibitors, Interleukin-23 - antagonists & inhibitors, Lymphoma - etiology, Medical sciences, Metabolic Syndrome - complications, Methotrexate - adverse effects, Obesity - complications, Psoriasis - complications, Psoriasis - drug therapy, Psoriasis. Parapsoriasis. Lichen, PUVA Therapy, Receptors, Tumor Necrosis Factor, Recombinant Fusion Proteins - therapeutic use, Smoking - adverse effects, Tumor Necrosis Factor-alpha - antagonists & inhibitors